BMD003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMD003, covering 2025-05-08 to 2025-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Single-center, Open-label Clinical Study to Evaluate the Safety and Efficacy of Inhaled BMD003(CFTR mRNA) in Chinese Adult Patients With Cystic Fibrosis [EARLY_Phase 1]